Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Prepaid Assets (2016 - 2025)

Avalo Therapeutics (AVTX) has disclosed Prepaid Assets for 12 consecutive years, with $2.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Prepaid Assets rose 137.67% year-over-year to $2.1 million, compared with a TTM value of $2.1 million through Sep 2025, up 137.67%, and an annual FY2024 reading of $4.3 million, up 413.05% over the prior year.
  • Prepaid Assets was $2.1 million for Q3 2025 at Avalo Therapeutics, up from $1.9 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $4.3 million in Q4 2024 and bottomed at $100000.0 in Q1 2024.
  • Average Prepaid Assets over 5 years is $1.6 million, with a median of $1.6 million recorded in 2023.
  • The sharpest move saw Prepaid Assets crashed 93.85% in 2024, then skyrocketed 1803.0% in 2025.
  • Year by year, Prepaid Assets stood at $2.4 million in 2021, then tumbled by 45.62% to $1.3 million in 2022, then tumbled by 34.65% to $843000.0 in 2023, then soared by 413.05% to $4.3 million in 2024, then crashed by 50.54% to $2.1 million in 2025.
  • Business Quant data shows Prepaid Assets for AVTX at $2.1 million in Q3 2025, $1.9 million in Q2 2025, and $1.8 million in Q1 2025.